SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058670
Filing Date
2021-11-12
Accepted
2021-11-12 16:06:13
Documents
64
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_chinapharma.htm   iXBRL 10-Q 539852
2 CERTIFICATION f10q0921ex31-1_chinapharma.htm EX-31.1 8671
3 CERTIFICATION f10q0921ex31-2_chinapharma.htm EX-31.2 8843
4 CERTIFICATION f10q0921ex32-1_chinapharma.htm EX-32.1 5358
  Complete submission text file 0001213900-21-058670.txt   3552164

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20210930.xsd EX-101.SCH 44648
6 XBRL CALCULATION FILE cphi-20210930_cal.xml EX-101.CAL 37209
7 XBRL DEFINITION FILE cphi-20210930_def.xml EX-101.DEF 189260
8 XBRL LABEL FILE cphi-20210930_lab.xml EX-101.LAB 374060
9 XBRL PRESENTATION FILE cphi-20210930_pre.xml EX-101.PRE 198063
10 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_chinapharma_htm.xml XML 319059
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 211403406
SIC: 2834 Pharmaceutical Preparations